Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
This study has been completed.
Study NCT01577914   Information provided by IPCA Laboratories Ltd.

First Received on April 12, 2012.   Last Updated on July 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fasting State
Interventions listed in this trial
Carvedilol Tablets USP 12.5 mg
Carvedilol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
IPCA Laboratories Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services